2024 annual financial data
Anixa Biosciences 2024 Operating margin
Anixa Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -13,831,000 USD and net income was -12,554,000 USD.
Operating cash flow was -7,335,000 USD.
Get free Anixa Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,831,000 USD
- Net income
- -12,554,000 USD
- Operating cash flow
- -7,335,000 USD